3D/L Capital Management’s Northern Trust Morningstar Global Upstream Natural Resources ETF GUNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,835
Closed -$317K 37
2023
Q3
$317K Buy
7,835
+74
+1% +$3.03K 0.1% 69
2023
Q2
$311K Buy
7,761
+1,764
+29% +$72.8K 0.09% 73
2023
Q1
$254K Buy
5,997
+570
+11% +$24.8K 0.07% 90
2022
Q4
$236K Buy
+5,427
New +$230K 0.06% 92
2022
Q3
Sell
-7,292
Closed -$289K 104
2022
Q2
$289K Buy
7,292
+113
+2% +$5.11K 0.08% 77
2022
Q1
$336K Sell
7,179
-1,371
-16% -$59.7K 0.08% 89
2021
Q4
$338K Buy
8,550
+81
+1% +$3.13K 0.08% 94
2021
Q3
$310K Buy
8,469
+2,250
+36% +$83.8K 0.07% 96
2021
Q2
$238K Buy
6,219
+271
+5% +$10.5K 0.06% 118
2021
Q1
$215K Buy
+5,948
New +$212K 0.05% 113

Other funds holding GUNR

3D/L Capital Management's GUNR Position: Q4 2023 in Review

3D/L Capital Management sold out of Northern Trust Morningstar Global Upstream Natural Resources ETF (GUNR) in Q4 2023, closing a stake of 7,835 shares — an estimated $317K sold.

3D/L Capital Management first reported a position in GUNR in Q1 2021 and held it in 10 quarters. The position peaked at $338K in Q4 2021. 292 funds tracked by Wall St. Rank hold GUNR as of Q4 2023.

  • 3D/L Capital Management reported no remaining Northern Trust Morningstar Global Upstream Natural Resources ETF position as of Q4 2023 after selling out during the quarter.
  • 3D/L Capital Management sold 7,835 Northern Trust Morningstar Global Upstream Natural Resources ETF shares in Q4 2023, an estimated $317K.
  • 3D/L Capital Management first reported a position in Northern Trust Morningstar Global Upstream Natural Resources ETF in Q1 2021 and held it in 10 quarters.
  • 3D/L Capital Management's Northern Trust Morningstar Global Upstream Natural Resources ETF position peaked at $338K in Q4 2021.
  • 292 funds tracked by Wall St. Rank held Northern Trust Morningstar Global Upstream Natural Resources ETF as of Q4 2023.

Based on 3D/L Capital Management's 13F filing for Q4 2023.